SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-002582
Filing Date
2023-01-26
Accepted
2023-01-26 14:53:09
Documents
12
Period of Report
2023-01-25
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38321
  Complete submission text file 0001493152-23-002582.txt   206652

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bstg-20230125.xsd EX-101.SCH 3227
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bstg-20230125_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bstg-20230125_pre.xml EX-101.PRE 22359
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3278
Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746
Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300
Biostage, Inc. (Filer) CIK: 0001563665 (see all company filings)

IRS No.: 455210462 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35853 | Film No.: 23557121
SIC: 3841 Surgical & Medical Instruments & Apparatus